Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoCyte Corp OCX

Healthcare Biotechnology
Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict... see more

Recent & Breaking News (NDAQ:OCX)

Oncocyte Reports Third Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2020

Oncocyte to Present DetermaIO(TM) Test Data at the 2020 Society for Immunotherapy of Cancer (SITC) Conference

GlobeNewswire November 9, 2020

Oncocyte to Report Third Quarter 2020 Financial Results on Thursday, November 12

GlobeNewswire November 2, 2020

Oncocyte Named One of the 2020 Best Places to Work in Orange County in Its First Year in Irvine, CA

GlobeNewswire October 28, 2020

Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer

Livemoney October 22, 2020

Oncocyte Announces Third Quarter Growth of DetermaRx(TM) Physician Adoption and Testing Volume

GlobeNewswire October 20, 2020

Oncocyte Announces New Prospective Data Demonstrating That Treatment Informed by DetermaRx(TM) Significantly Improves Lung Cancer Patient Survival

GlobeNewswire October 14, 2020

Oncocyte and Fondazione Michelangelo, a Leading Non-Profit Cancer Research Foundation, Announce Immune Therapy Biomarker Collaboration

GlobeNewswire October 8, 2020

Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical

GlobeNewswire October 1, 2020

Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer

GlobeNewswire September 15, 2020

Oncocyte to Participate at the Lake Street Capital Markets 4th Annual Best Ideas Growth Conference

GlobeNewswire September 14, 2020

Oncocyte Receives Final Pricing Decision for DetermaRx(TM) Molecular Test for Lung Cancer from Centers for Medicare and Medicaid Services

GlobeNewswire September 9, 2020

Oncocyte and the Guardian Research Network® Announce Strategic Alliance

GlobeNewswire September 3, 2020

Oncocyte to Present at the LD 500 Virtual Conference

Accesswire September 1, 2020

(LD Micro) 360 Companies Set to Present this Week

Accesswire August 31, 2020

Oncocyte Announces Addition of Experienced Healthcare Executive, Jennifer Carter, MD, MPH, MBA to Board of Directors

GlobeNewswire August 27, 2020

Oncocyte to Participate at Needham Virtual Cancer Diagnostics Conference

GlobeNewswire August 13, 2020

Oncocyte to Hold KOL Webinar Highlighting Clinical Data on Its DetermaIO(TM) Test for Immunotherapy Response Prediction

GlobeNewswire August 11, 2020

Oncocyte Provides Corporate Update and Reports Second Quarter 2020 Financial Results

GlobeNewswire July 29, 2020

Oncocyte Announces Rapid Adoption of DetermaRx(TM) in Community Health Systems

GlobeNewswire July 28, 2020